Q1 2024 Earnings Forecast for NewAmsterdam Pharma (NASDAQ:NAMS) Issued By Leerink Partnrs
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Investment analysts at Leerink Partnrs cut their Q1 2024 earnings per share (EPS) estimates for shares of NewAmsterdam Pharma in a research note issued on Wednesday, February 28th. Leerink Partnrs analyst R. Ruiz now forecasts that the company will post earnings per share of ($0.55) for the quarter, […]
More Stories
iShares MSCI Europe Financials ETF (NASDAQ:EUFN) Sees Strong Trading Volume – What’s Next?
iShares MSCI Europe Financials ETF (NASDAQ:EUFN – Get Free Report) shares saw strong trading volume on Monday . 77,079 shares...
United Natural Foods (NYSE:UNFI) Trading Down 3.6% – Here’s Why
United Natural Foods, Inc. (NYSE:UNFI – Get Free Report) shares fell 3.6% on Monday . The stock traded as low...
Globus Medical (NYSE:GMED) Updates FY 2025 Earnings Guidance
Globus Medical (NYSE:GMED – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The...
Ciena Co. (NYSE:CIEN) Director Bruce L. Claflin Sells 16,912 Shares
Ciena Co. (NYSE:CIEN – Get Free Report) Director Bruce L. Claflin sold 16,912 shares of Ciena stock in a transaction...
Insider Selling: Coinbase Global, Inc. (NASDAQ:COIN) Director Sells 22,842 Shares of Stock
Coinbase Global, Inc. (NASDAQ:COIN) Director Frederick Ernest Ehrsam III sold 22,842 shares of the firm’s stock in a transaction on...
Smartsheet Inc (NYSE:SMAR) CEO Sells $280,350.00 in Stock
Smartsheet Inc (NYSE:SMAR – Get Free Report) CEO Mark Patrick Mader sold 5,000 shares of the firm’s stock in a...